91 – 99 of 99
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2000
-
Mark
Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer
(
- Contribution to journal › Article
-
Mark
Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum
(
- Contribution to journal › Article
- 1999
-
Mark
Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy
(
- Contribution to journal › Article
- 1995
-
Mark
Prostaglandin E2-induced bladder hyperactivity in normal, conscious rat. Involvement of tachykinins?
(
- Contribution to journal › Article
-
Mark
Effects of neurokinin receptor antagonists on L-dopa induced bladder hyperactivity in normal conscious rats.
(
- Contribution to journal › Article
- 1993
-
Mark
Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer
(
- Contribution to journal › Article
-
Mark
Effects of long-term treatment with estrogen and progesterone on in vitro muscle responses of the female rabbit urinary bladder and urethra to autonomic drugs and nerve stimulation
(
- Contribution to journal › Article
-
Mark
Lactate dehydrogenase activity and isoform distribution in the rat urinary bladder: effects of outlet obstruction and its removal
(
- Contribution to journal › Article
- 1984
-
Mark
The influence of treatment with estrogens and estramustine phosphate on platelet aggregation and plasma lipoproteins in non-disseminated prostatic carcinoma
(
- Contribution to journal › Article